Skip to content

Clinical trials

Phase 1 Autoimmune Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 1 Country / region: China Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20191
20201
20214
20223
20231
202414
202516
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting24
Not yet recruiting10
Unknown status8
Completed5
Withdrawn4
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zhejiang University7
The Children's Hospital of Zhejiang University School of Medicine6
Changhai Hospital3
Nanjing Legend Biotech Co.3
Beijing Boren Hospital2
Changchun GeneScience Pharmaceutical Co., Ltd.2
China Immunotech (Beijing) Biotechnology Co., Ltd.2
Chinese PLA General Hospital2
Nanjing Bioheng Biotech Co., Ltd.2
RenJi Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases53
Lupus Erythematosus, Systemic19
Scleroderma, Systemic11
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis9
Myositis8
Recurrence6
Glomerulonephritis, IGA5
Nephrotic Syndrome5
Sjogren's Syndrome5
Antiphospholipid Syndrome3

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.